pH and glucose sensing in Trypanosoma brucei glycosomes
pH and glucose sensing in Trypanosoma brucei glycosomes
批准号:
8624128
负责人:
KENNETH A CHRISTENSEN
金额:
$19.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-12 至 2015-11-30
关键词:
AffectAfrica South of the SaharaAfricanAfrican TrypanosomiasisAreaBiologyBlood CirculationCalcium SignalingCarbonCellsCessation of lifeChagas DiseaseConsumptionCuesDataDevelopmentDrug DesignDrug resistanceEndoplasmic ReticulumEnvironmentEnzymesFailureFluorescent ProbesFoundationsGlucoseGlycolysisGlycosomeGoalsGolgi ApparatusHIVHousingHumanIndividualLeishmaniaLeishmaniasisLifeMeasurementMediatingMetabolicMetabolic PathwayMetabolismMethodologyMissionMitochondriaMonitorMorbidity - disease rateNutrientOrganellesOrganismParasitesParasitic DiseasesPathway interactionsPeptidesPharmaceutical PreparationsPharmacotherapyProductionProteinsPublic HealthQuantitative EvaluationsRecombinant ProteinsRecombinantsRegulationResearchSepsisSeriesSodium ChlorideSolutionsSourceStagingTechniquesTemperatureTestingToxic effectTreatment FailureTrypanosomaTrypanosoma brucei bruceiTrypanosoma cruziTrypanosomiasisWorkbasedeprivationdesigneconomic costenvironmental changeenzyme activityenzyme mechanismextracellularglucose metabolismglucose sensorhexokinasein vivokillingsmortalitynovel strategiesperoxisomepublic health relevanceratiometricresponsesensorsmall moleculesocialsolutesugartherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
African trypanosomiasis, also called African sleeping sickness, infects tens of thousands of individuals yearly in
endemic areas, and is accompanied by continuing high social and economic cost. Existing treatments for
trypanosomiasis are woefully inadequate, due both to the emergence of drug resistance that results in high
treatment failures rates (30% in some areas), and high toxicity resulting in significant morbidity (10%) and
drug-related mortality (5%). There thus remains an outstanding need for rational design of new trypanocidal
therapies, particularly those that minimize host toxicity by targeting unique trypanosome biology. Glucose
metabolism is the sole source of ATP for the infectious lifecycle stage of the African trypanosome,
Trypanosoma brucei, and enzymes central to sugar metabolism are housed in the glycosome, an organelle not
found in the parasite's mammalian host(s). Hence, both glycosome function and the control mechanisms
governing enzyme activity inside the glycosome are important targets for drug design. We have demonstrated
that ATP production in this organism is sensitive to environmentally-influenced changes in glycosomal solution
conditions, including pH. Characterizing the intraglycosomal environment is therefore a necessary step in
understanding essential glycolytic pathways, and would lay the groundwork for development of anti-
trypanosome therapies that target control of glucose metabolism. However, this information is currently lacking
at the most basic level. Neither pH nor glucose has been quantified inside the glycosome and their
environmentally influenced dynamic range(s) are unknown, a paucity that reflects the historical lack of
methodologies to allow quantitative intraglycosomal measurement. Here we propose development of peptide-
targeted small molecule and recombinant protein-based sensors to quantitatively determine intraglycosomal
pH and glucose levels. Our preliminary data indicates that such sensors can be delivered to the glycosomes of
live parasites. Developed sensors can be subsequently modified for measurement of other glycosomal
solutes, including ATP, and used to investigate control of glycolysis as a response to other potentially
important environmental and developmental conditions, including glucose and divalent salt concentrations,
nutrient depletion, and calcium signaling. Resulting findings will illuminate the mechanisms of dynamic
regulation of the glycosomal environment, reveal conditions that influence the activity of this essential
metabolic pathway, and introduce methodologies likely facilitate a series of new approaches to understanding
and testing parasite metabolism. Notably, techniques pioneered in this study can be extended to analysis of
other pathogenic kinetoplastid parasites, such as Trypanasoma cruzi and Leishmania spp. that also localize
ATP production in glycosomes. In addition, the methodologies can be modified to evaluate the intraorganellar
environment in other important subcellular compartments such as the mitochondria, endoplasmic reticulum,
and Golgi apparatus. The work is therefore likely to have impact(s) beyond African trypanosomiasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis
-
批准号:10382390
-
项目类别:
-
资助金额:$49.75万
-
财政年份:2021
-
负责人:KENNETH A CHRISTENSEN
-
依托单位:
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis
-
批准号:10113252
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2021
-
负责人:KENNETH A CHRISTENSEN
-
依托单位:
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis
-
批准号:10590578
-
项目类别:
-
资助金额:$52.46万
-
财政年份:2021
-
负责人:KENNETH A CHRISTENSEN
-
依托单位:
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis
-
批准号:10542968
-
项目类别:
-
资助金额:$1.88万
-
财政年份:2021
-
负责人:KENNETH A CHRISTENSEN
-
依托单位:
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis
-
批准号:10774367
-
项目类别:
-
资助金额:$6.61万
-
财政年份:2021
-
负责人:KENNETH A CHRISTENSEN
-
依托单位:
pH and glucose sensing in Trypanosoma brucei glycosomes
-
批准号:9077835
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2013
-
负责人:KENNETH A CHRISTENSEN
-
依托单位:
Assay:Molecules that Inhibit Anthrax Intoxication(RMI)
-
批准号:7021313
-
项目类别:
-
资助金额:$8.82万
-
财政年份:2005
-
负责人:KENNETH A CHRISTENSEN
-
依托单位:
海外基金